Health Care Innovation
Commentary
Biden’s health care plans – this is what Americans can expect from Democrats
Last week, President Joe Biden signed executive orders that will re-open ObamaCare’s insurance exchanges from Feb. 15 through May 15 and direct federal agencies to re-examine some of the health care rules enacted by the Trump administration. There’s a limit to what Biden can accomplish by executive action. But with narrow control of Congress, there’s still plenty ...
Blog
It’s the Payment System
Effectively addressing the drug affordability problem requires an understanding of its causes. Toward this end, the rhetoric of Matt Eyles, the president and chief executive of America’s Health Insurance Plans (AHIP), is unhelpful. According to Eyles, “Americans are being hurt by out-of-control drug prices, which are set and fully controlled ...
Commentary
Biden officials threaten to jumpstart single-payer health care systems
Move over, Bidencare. Single-payer health care could be coming to the United States. President-elect Joe Biden’s nominee to lead the Department of Health and Human Services, California Attorney General Xavier Becerra, is a longtime supporter of Medicare for All. If confirmed, he’ll have the power to approve waivers that would allow states ...
California
A Single-Payer Healthcare System Would Have Made the Pandemic Worse
The intended-to-scare-readers headline said “California hospitals discuss rationing care as virus surges.” And it should frighten anyone who saw it. Though not necessarily for the reason the headline writer had in mind. The alarmist string of words topped a Dec. 21 Associated Press story, which warned that “overwhelmed hospitals” in ...
Drug Pricing
NEW BRIEF: Tearing Down Drug ‘Rebate Walls’ Would Save Patients, Improve Health Care Outcomes
Tearing down drug “rebate walls” that increase patient costs and block access to cheaper and often more effective medications would increase competition, lower out-of-pocket costs, and improve health outcomes, finds a new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute. Click ...
Commentary
For HHS post Biden taps ObamaCare’s lead defender – don’t expect him to be a moderate
President-elect Joe Biden announced Monday that he plans to nominate California Attorney General Xavier Becerra to be his Secretary of Health and Human Services. It’s a conventional, if unexpected, pick. The Washington rumor mill had New Mexico Governor Michelle Lujan Grisham and Rhode Island Governor Gina Raimondo as the front-runners to lead HHS until ...
Commentary
Trump wrongly attacks life-saving drug companies on coronavirus vaccines and more
President Trump announced Friday that he will proceed with his plans to peg the prices of certain drugs prescribed largely at doctors’ offices under Medicare Part B to the lower prices that other developed nations pay for those drugs. That may sound good at first glance, but in reality, the move will slow ...
Drug Importation
NEW BRIEF: Counterfeit Drugs Harm Patients, Economy, Innovation
A new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute shows that counterfeit drugs put patients in harm’s way, hinder drug innovation, and lead to job losses. Proposals like drug importation or price controls, if implemented, would exacerbate the problem and ...
Commentary
Import German drug prices to the United States? Nein, danke
President Trump recently issued a blitz of executive orders in an attempt to fulfill his promise to reduce drug prices. One of those orders would put in place a “cure” far worse than the disease. The order in question establishes foreign reference pricing, whereby the federal government ties its reimbursement rates for ...
Drug Pricing
Wayne Winegarden Featured in Newsweek Drug Pricing Story
Title: Big Pharma Backs Joe Biden, But People Don’t Think He’ll Fix Drug Pricing By Darragh Roche Former Vice President Joe Biden is winning the race for donations from Big Pharma but experts and industry stakeholders doubt his plans will successfully lower drug prices or address underlying issues in the ...
Biden’s health care plans – this is what Americans can expect from Democrats
Last week, President Joe Biden signed executive orders that will re-open ObamaCare’s insurance exchanges from Feb. 15 through May 15 and direct federal agencies to re-examine some of the health care rules enacted by the Trump administration. There’s a limit to what Biden can accomplish by executive action. But with narrow control of Congress, there’s still plenty ...
It’s the Payment System
Effectively addressing the drug affordability problem requires an understanding of its causes. Toward this end, the rhetoric of Matt Eyles, the president and chief executive of America’s Health Insurance Plans (AHIP), is unhelpful. According to Eyles, “Americans are being hurt by out-of-control drug prices, which are set and fully controlled ...
Biden officials threaten to jumpstart single-payer health care systems
Move over, Bidencare. Single-payer health care could be coming to the United States. President-elect Joe Biden’s nominee to lead the Department of Health and Human Services, California Attorney General Xavier Becerra, is a longtime supporter of Medicare for All. If confirmed, he’ll have the power to approve waivers that would allow states ...
A Single-Payer Healthcare System Would Have Made the Pandemic Worse
The intended-to-scare-readers headline said “California hospitals discuss rationing care as virus surges.” And it should frighten anyone who saw it. Though not necessarily for the reason the headline writer had in mind. The alarmist string of words topped a Dec. 21 Associated Press story, which warned that “overwhelmed hospitals” in ...
NEW BRIEF: Tearing Down Drug ‘Rebate Walls’ Would Save Patients, Improve Health Care Outcomes
Tearing down drug “rebate walls” that increase patient costs and block access to cheaper and often more effective medications would increase competition, lower out-of-pocket costs, and improve health outcomes, finds a new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute. Click ...
For HHS post Biden taps ObamaCare’s lead defender – don’t expect him to be a moderate
President-elect Joe Biden announced Monday that he plans to nominate California Attorney General Xavier Becerra to be his Secretary of Health and Human Services. It’s a conventional, if unexpected, pick. The Washington rumor mill had New Mexico Governor Michelle Lujan Grisham and Rhode Island Governor Gina Raimondo as the front-runners to lead HHS until ...
Trump wrongly attacks life-saving drug companies on coronavirus vaccines and more
President Trump announced Friday that he will proceed with his plans to peg the prices of certain drugs prescribed largely at doctors’ offices under Medicare Part B to the lower prices that other developed nations pay for those drugs. That may sound good at first glance, but in reality, the move will slow ...
NEW BRIEF: Counterfeit Drugs Harm Patients, Economy, Innovation
A new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute shows that counterfeit drugs put patients in harm’s way, hinder drug innovation, and lead to job losses. Proposals like drug importation or price controls, if implemented, would exacerbate the problem and ...
Import German drug prices to the United States? Nein, danke
President Trump recently issued a blitz of executive orders in an attempt to fulfill his promise to reduce drug prices. One of those orders would put in place a “cure” far worse than the disease. The order in question establishes foreign reference pricing, whereby the federal government ties its reimbursement rates for ...
Wayne Winegarden Featured in Newsweek Drug Pricing Story
Title: Big Pharma Backs Joe Biden, But People Don’t Think He’ll Fix Drug Pricing By Darragh Roche Former Vice President Joe Biden is winning the race for donations from Big Pharma but experts and industry stakeholders doubt his plans will successfully lower drug prices or address underlying issues in the ...
